Essex Financial Services Inc. boosted its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 3.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,959 shares of the company’s stock after purchasing an additional 105 shares during the period. Essex Financial Services Inc.’s holdings in McKesson were worth $1,687,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wolff Wiese Magana LLC raised its stake in shares of McKesson by 742.9% in the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after acquiring an additional 52 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in McKesson during the 3rd quarter valued at $29,000. RPg Family Wealth Advisory LLC bought a new position in McKesson in the 3rd quarter valued at $31,000. Synergy Asset Management LLC acquired a new position in McKesson in the fourth quarter worth $32,000. Finally, Crews Bank & Trust acquired a new stake in shares of McKesson in the fourth quarter valued at $33,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, EVP Leann B. Smith sold 579 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the completion of the sale, the executive vice president now owns 864 shares of the company’s stock, valued at $494,890.56. This represents a 40.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.11% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Check Out Our Latest Research Report on McKesson
McKesson Trading Up 1.2 %
Shares of MCK opened at $610.57 on Wednesday. The stock has a market cap of $77.51 billion, a P/E ratio of 27.96, a price-to-earnings-growth ratio of 1.30 and a beta of 0.52. McKesson Co. has a 1 year low of $464.42 and a 1 year high of $637.51. The stock’s 50-day moving average price is $588.04 and its two-hundred day moving average price is $562.60.
McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. As a group, equities analysts forecast that McKesson Co. will post 32.69 EPS for the current year.
McKesson Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date is Monday, March 3rd. McKesson’s dividend payout ratio is currently 13.00%.
McKesson Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
- Five stocks we like better than McKesson
- ESG Stocks, What Investors Should Know
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- What Are Dividend Challengers?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.